The France Digital X-Ray Devices Market size is estimated at USD 673.84 million in 2024, and is expected to reach USD 949.97 million by 2029, growing at a CAGR of 7.11% during the forecast period (2024-2029).
The healthcare sector in France has suffered as a result of decreased demand during the first wave of COVID-19, to keep hospitals and clinics free for COVID-19 patients as well as the risk of spreading the infection, and as a result, all non-essential treatments and surgeries were postponed by healthcare institutions. To combat the outbreak, the National Cancer Institute delayed and canceled all cancer screenings throughout the lockdown in France. Several patients with cancer signs avoided attending a dedicated diagnostic center or their oncologist's office once the lockdown ended, even though normal tests had resumed. Researchers discovered a 31% decrease in new referrals for colorectal cancer in 2020 (March to May) compared to the average of the previous two years, according to the article 'Effect of the COVID-19 pandemic on colorectal cancer care in France' published in May 2021. The pandemic, on the other hand, has shifted the focus away from cancer care. This resulted in a lesser number of screenings within the country, thereby, impacting the total of digital x-ray scans performed across the country.
However, COVID-19 has opened up newer opportunities for digital X-ray manufacturers and healthcare providers. When laboratory testing (RT-PCR) is not available, or results are delayed or initially negative, chest imaging has been investigated as an alternative option for people with suspected or probable COVID-19. As a result, the demand for digital x-ray imaging is expected to bolster in the post-pandemic phase within the country.
The advantages of digital x-ray imaging devices over traditional x-ray systems are likely to boost the market growth in France. Furthermore, the growth of the market is further augmented by the increasing use of digital x-ray imaging in the diagnosis of cancers, orthopedic and cardiovascular diseases. Increasing funding and government initiatives toward digital health also play important role in driving the growth of the market studied in France. For instance, in November 2021, French health minister Olivier Véran announced an investment plan of EUR 650 million to accelerate the country's digital health strategy. Other funding areas include digital training for healthcare professionals, scientific innovation, and large-scale deployment of digital health in France and internationally. Furthermore, according to the United Nations Population Fund's World Population Dashboard's Statistics 2021, about 21.1 percent of individuals in France are 65 or older. Since chronic diseases are more common among the elderly, the need for monitoring, diagnosis, and treatment devices is predicted to rise over the forecast period.
According to the International Agency for Research on Cancer published Globocan 2020 report, the estimated number of breast cancer cases in 2020 was 58,083 in France. Additionally, according to the same report, the estimated number of prostate cancer cases in 2020 was 66,070. The deaths from prostrate cancer cases were calculated to be 9,060. The high burden of different types of cancer disorders in France is expected to boost the demand for digital x-rays for diagnosis purposes. This is expected to boost the market growth during the forecast period.
Many research studies are taking place in France in the field of digital x-ray imaging for cancer diagnosis. For instance, in September 2021, an article titled, 'Validation of lung nodule detection a year before diagnosis in NLST (National Lung Screening Trial) dataset based on a deep learning system' was published that states that the artificial intelligence (AI) program developed by NLST can spot signs of lung cancer on CT scan a year before they can be diagnosed with existing methods. Such studies that involve x-ray-based CT scans for cancer disease diagnosis are believed to boost the market growth during the forecast period.
Hence, the above developments are further expected to improve the market growth in this segment.
This product will be delivered within 2 business days.
The healthcare sector in France has suffered as a result of decreased demand during the first wave of COVID-19, to keep hospitals and clinics free for COVID-19 patients as well as the risk of spreading the infection, and as a result, all non-essential treatments and surgeries were postponed by healthcare institutions. To combat the outbreak, the National Cancer Institute delayed and canceled all cancer screenings throughout the lockdown in France. Several patients with cancer signs avoided attending a dedicated diagnostic center or their oncologist's office once the lockdown ended, even though normal tests had resumed. Researchers discovered a 31% decrease in new referrals for colorectal cancer in 2020 (March to May) compared to the average of the previous two years, according to the article 'Effect of the COVID-19 pandemic on colorectal cancer care in France' published in May 2021. The pandemic, on the other hand, has shifted the focus away from cancer care. This resulted in a lesser number of screenings within the country, thereby, impacting the total of digital x-ray scans performed across the country.
However, COVID-19 has opened up newer opportunities for digital X-ray manufacturers and healthcare providers. When laboratory testing (RT-PCR) is not available, or results are delayed or initially negative, chest imaging has been investigated as an alternative option for people with suspected or probable COVID-19. As a result, the demand for digital x-ray imaging is expected to bolster in the post-pandemic phase within the country.
The advantages of digital x-ray imaging devices over traditional x-ray systems are likely to boost the market growth in France. Furthermore, the growth of the market is further augmented by the increasing use of digital x-ray imaging in the diagnosis of cancers, orthopedic and cardiovascular diseases. Increasing funding and government initiatives toward digital health also play important role in driving the growth of the market studied in France. For instance, in November 2021, French health minister Olivier Véran announced an investment plan of EUR 650 million to accelerate the country's digital health strategy. Other funding areas include digital training for healthcare professionals, scientific innovation, and large-scale deployment of digital health in France and internationally. Furthermore, according to the United Nations Population Fund's World Population Dashboard's Statistics 2021, about 21.1 percent of individuals in France are 65 or older. Since chronic diseases are more common among the elderly, the need for monitoring, diagnosis, and treatment devices is predicted to rise over the forecast period.
France Digital X-Ray Devices Market Trends
Cancer is Believed to Witness Strong Growth Over the Forecast Period
Factors such as the rise in prevalence of different cancer disorders (like breast, prostate, lung, and so on) and greater applications of digital x-ray in diagnosing cancer disorders are the major factors attributing to the growth of this segment in France. Many research studies are also being conducted that can boost innovation and market growth.According to the International Agency for Research on Cancer published Globocan 2020 report, the estimated number of breast cancer cases in 2020 was 58,083 in France. Additionally, according to the same report, the estimated number of prostate cancer cases in 2020 was 66,070. The deaths from prostrate cancer cases were calculated to be 9,060. The high burden of different types of cancer disorders in France is expected to boost the demand for digital x-rays for diagnosis purposes. This is expected to boost the market growth during the forecast period.
Many research studies are taking place in France in the field of digital x-ray imaging for cancer diagnosis. For instance, in September 2021, an article titled, 'Validation of lung nodule detection a year before diagnosis in NLST (National Lung Screening Trial) dataset based on a deep learning system' was published that states that the artificial intelligence (AI) program developed by NLST can spot signs of lung cancer on CT scan a year before they can be diagnosed with existing methods. Such studies that involve x-ray-based CT scans for cancer disease diagnosis are believed to boost the market growth during the forecast period.
Hence, the above developments are further expected to improve the market growth in this segment.
France Digital X-Ray Devices Industry Overview
The France X-ray devices market is nearly consolidated and moderately competitive as per the competitive analysis owing to the few companies that are currently dominating the market. These companies include GE Healthcare, Koninklijke Philips NV, Fujifilm Holdings Corporation, Siemens Healthineers, and Canon Medical System Corporation (Toshiba Corporation) among others. The competition in the market is majorly based on technological advances and the pricing of digital X-ray equipment. Additionally, the key players have been involved in various strategic alliances such as acquisitions, and collaborations along with the launch of advanced products to secure their position in the market.Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Methodology
LOADING...
